Skip to main navigation
  • Home
  • Synthetic Biology
    • The History of Synthetic Biology
  • Living Medicines
    • Designing Synthetic Biotic™ Medicines
  • Pipeline + Programs
    • Partner with Us
  • For Patients
  • Our People
    • Leadership
    • Board of Directors
    • Founders and Advisors
    • Join Us
  • Investors + Media
    • Company Overview
    • News & Events
      • News Releases
      • Events
      • In the News
    • Presentations & Publications
    • Stock Information
    • Corporate Governance
    • Financials
    • Investor Resources
explore the
possibilities

Synlogic Therapeutics

Investor Relations

In the News

  • Home
  • Synthetic Biology
    • The History of Synthetic Biology
  • Living Medicines
    • Designing Synthetic Biotic™ Medicines
  • Pipeline + Programs
    • Partner with Us
  • For Patients
  • Our People
    • Leadership
    • Board of Directors
    • Founders and Advisors
    • Join Us
  • Investors + Media
    • Company Overview
    • News & Events
      • News Releases
      • Events
      • In the News
    • Presentations & Publications
    • Stock Information
    • Corporate Governance
    • Financials
    • Investor Resources
CMO Chief Medical Officer 360° Newsletter August 2020
Source
CMO360°
August 1, 2020
Bacteria as Living Microrobots to Fight Cancer
Source
The Scientist Magazine
April 1, 2020
Turning Synthetic Biology Into 'Living Drugs': Synlogics Aoife Brennan on The Long Run
Source
Timmerman Report
October 15, 2019
How phenylketonuria, a once-neglected disease, became a proving ground for new drugs
Source
Chemical & Engineering News (C&EN)
July 8, 2019

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Current page 3
  • Email Alerts
  • Contact IR
  • RSS Feeds
  • Print Page
  • Email Page

Synlogic Therapeutics

Contact

Synlogic

301 Binney St #402
Cambridge, MA 02142

info@synlogictx.com
(617) 401-9975

  • Twitter
  • LinkedIn

Privacy and Terms

© 2018 Synlogic
Privacy Policy